Recombinant multi-species Septin 9/SEPT9/SEPTIN9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Septin 9/SEPT9/SEPTIN9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Mar 2009]
The Alternative Names of target: AF17q25,Eseptin,MLL septin-like fusion protein MSF-A (MLL septin-like fusion protein),MSF,MSF1,Msf,NAPB,Ovarian/Breast septin (Ov/Br septin),PNUTL4,SEPT9,SEPTIN9,SINT1,Sept9,SeptD1,Septin 9,Septin D1,Septin-9,Septin9,Septin9l1,Sint1,Slpa

Target products collectionGo to Septin 9/SEPT9/SEPTIN9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3818-Ag-1/ GM-Tg-hg-IP3818-Ag-2 Human Septin 9/SEPT9/SEPTIN9 protein Human
GM-Tg-rg-IP3818-Ag-1/ GM-Tg-rg-IP3818-Ag-2 Rat Septin 9/SEPT9/SEPTIN9 protein Rat
GM-Tg-mg-IP3818-Ag-1/ GM-Tg-mg-IP3818-Ag-2 Mouse Septin 9/SEPT9/SEPTIN9 protein Mouse
GM-Tg-cynog-IP3818-Ag-1/ GM-Tg-cynog-IP3818-Ag-2 Cynomolgus/Rhesus macaque Septin 9/SEPT9/SEPTIN9 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3818-Ag-1/ GM-Tg-felg-IP3818-Ag-2 Feline Septin 9/SEPT9/SEPTIN9 protein Feline
GM-Tg-cang-IP3818-Ag-1/ GM-Tg-cang-IP3818-Ag-2 Canine Septin 9/SEPT9/SEPTIN9 protein Canine
GM-Tg-bovg-IP3818-Ag-1/ GM-Tg-bovg-IP3818-Ag-2 Bovine Septin 9/SEPT9/SEPTIN9 protein Bovine
GM-Tg-equg-IP3818-Ag-1/ GM-Tg-equg-IP3818-Ag-2 Equine Septin 9/SEPT9/SEPTIN9 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3818-Ag-1/ GM-Tg-hg-IP3818-Ag-2; GM-Tg-rg-IP3818-Ag-1/ GM-Tg-rg-IP3818-Ag-2;
GM-Tg-mg-IP3818-Ag-1/ GM-Tg-mg-IP3818-Ag-2; GM-Tg-cynog-IP3818-Ag-1/ GM-Tg-cynog-IP3818-Ag-2;
GM-Tg-felg-IP3818-Ag-1/ GM-Tg-felg-IP3818-Ag-2; GM-Tg-cang-IP3818-Ag-1/ GM-Tg-cang-IP3818-Ag-2;
GM-Tg-bovg-IP3818-Ag-1/ GM-Tg-bovg-IP3818-Ag-2; GM-Tg-equg-IP3818-Ag-1/ GM-Tg-equg-IP3818-Ag-2
Products Name Septin 9/SEPT9/SEPTIN9 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Septin 9/SEPT9/SEPTIN9
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Septin 9/SEPT9/SEPTIN9 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.